Aptamers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Type (DNA Aptamers, XNA Aptamers, RNA Aptamers), By Technology (SELEX, Others), By Application (Therapeutics Development, Research & Development, Diagnostics, Others), By End user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations, Other
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationAptamers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Type (DNA Aptamers, XNA Aptamers, RNA Aptamers), By Technology (SELEX, Others), By Application (Therapeutics Development, Research & Development, Diagnostics, Others), By End user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations, Other
Increasing Use Across Industries
According to global cancer observatory, around 19,292,789 new cancer cases were reported in 2020 worldwide, with Breast Cancer, Lung Cancer, Colorectum Cancer, Prostate Cancer, and Stomach Cancer being the most prevalent types.
Growing Awareness About Aptamers
The growing usage of aptamers by different industries and innovations happening related to aptamers has encouraged the market growth over the years. Also, growing awareness among the industries about various benefits associated with aptamers such as they are single stranded DNA and RNA molecules and can selectively bind to a specific target and have numerous advantages over monoclonal antibodies, is expected to spur the market growth through 2028. These molecules bind with targets including proteins, peptides, small molecules, toxins, carbohydrates and even live cells. It can be created by a selection process from a large random sequence pool, and it can be used for both clinical and research purposes.
Growing Prevalence of Chronic and Rare Diseases
According to a research study by US Healthcare Agency published in Electrochimica Acta Journal in April 2022, the study results found that aptamers have come into the spotlight as bio-mimetic molecular recognition elements in the field of biomedicine due to various applications in diagnostics, drug delivery, therapeutics, and pharmaceutical analysis.
Download Free Sample Report
Market Segmentation
Global Aptamers market can be segmented by type, technology, application, end user and by region. Based on type, the market can be segmented into DNA Aptamers, XNA Aptamers, RNA Aptamers. Based on Technology, the market can be divided into SELEX, Others. Based on application, the market can be differentiated into therapeutics development, research & development, diagnostics, and others. Based on end-user, the market can be grouped into pharmaceutical & biotechnology companies, academic & research institutions, contract research organizations, and others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America.
Recent Development
- In March 2021, Aptamer Group the developer of Optimerreagents announced its merger with Mologic, which is a manufacturer of lateralflow and rapid diagnostic test kits. The merger was executed with an aim tomanufacture testing kits for Novel Coronavirus i.e. SARS-CoV-2.
- In May 2020, Portage Biotech made an additional investment inSaugatuck therapeutics after achieving proof of concept. This has triggered thenext tranche of capital infusion of USD700,000. Saugatuck has been able toformulate a proprietary PD1 aptamer in the NLG formulation and have shown theformulation properly modulates PD1 signaling.
Market Players
Aptamer Group.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | By Type By Product By Application By End User By Region |
| Regional scope | North America, Europe, Asia Pacific, South America, Middle East & Africa |
| Country scope | United States, Canada, Mexico, France, Germany, United Kingdom, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Argentina, Colombia, South Africa, Saudi Arabia, UAE |
| Key companies profiled | Aptamer Group., Raptamer Discovery Group., Somalogic Inc., Aptamer Sciences, Inc., Aptagen LLC., Maravai Lifesciences., Kaneka Corporation., Neoventures Biotechnology Inc., Aptus Biotech., Base Pair Biotechnologies. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy